News

The AETC National Coordinating Resource Center and the University of Washington have developed the National HIV Curriculum, an educational web site offering free CME and CNE credits. 

The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment. Juluca is a fixed-dose tablet containing two previously approved drugs (dolutegravir and rilpivirine) to treat adults with HIV-1 infections whose virus is currently suppressed on a stable regimen for at least six months, with no history of treatment failure and no known substitutions associated with resistance to the individual components of Juluca.

 November is a time to be thankful for many reasons and here at OHAIDP, we are thankful for all our partners and our shared accomplishments.

The interest and follow up from our Hidden Casualties: Consequences of the Opioid Epidemic on the Spread of Infectious Diseases event has been phenomenal. The opioid crisis in the United States has reached epidemic levels. Our office, along with many of our partners, are continuing to address this critical health threat. If you haven’t seen the powerful webcast, you can read the event coverage in USA Today or view the event video with transcripts.

STD Curriculum launched

The University of Washington STD Prevention Training Center has developed the National STD Curriculum website addressing the epidemiology, pathogenesis, clinical manifestations, diagnosis, management, and prevention of chlamydia, gonorrhea, HSV, HPV, PID, syphilis and vaginitis. The website is free, integrates the most recent CDC STD Treatment Guidelines, and includes self-study modules for continuing education credits with interactive board-review style questions, and reference materials.

Washington DC, November 8, 2017 – The Liver Forum is pleased to announce the publication of its first manuscript, Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum,published as a Commentary in the September 2017 volume of the peer-reviewed journal Gastroenterology. The development of this manuscript included input and contributions from key opinion leaders in the field of NASH, and was led by Dr. Yuval Patel (Duke University), Dr. Andrew Muir (Duke University), and Dr. Joanne Imperial (Conatus Pharmaceuticals). The published article is available at: https://doi.org/10.1053/j.gastro.2017.07.024.

A message from Treatment Action Group

Now is the time to end the HIV/AIDS epidemic in America’s southern states.

Over the past four years, innovative Ending the Epidemic (EtE) plans have emerged in several jurisdictions across the nation following New York’s 2014 announcement that it will end the state’s HIV epidemic by 2020. While most of these plans have been announced for cities, counties, and states outside of the South, community advocates in Fulton County, Georgia blazed their own trail in 2014, working with local government to establish a task force and develop an EtE plan. Houston community advocates led a process to develop their own plan in partnership with the Houston Health Department, ultimately launching their Roadmap to Ending the HIV Epidemic in Houston in December of 2016.

One thing is abundantly clear: We can’t end the epidemic in the U.S. if we don’t end it in the South. 

A message from The U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP)

Greetings!

The U.S. Department of Health and Human Services (HHS) Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) is accepting applications for the 2018 Prevention Internship Program.

The Prevention Internship Program, a component of SAMHSA/CSAP’s Prevention Fellowship Program, invites qualified individuals with strong interest in substance abuse prevention and behavioral health, for a 5-month paid internship in participating Tribes and Tribal Organizations throughout the United States. (Visit the application Web site at www.seiservices.com/SAMHSA/csap/preventionfellowship for a list of participating locations.)

16th International Symposium on Viral Hepatitis and Liver Disease Global Hepatitis Summit 

Toronto, Canada, June 14-17, 2018

Congress registration will open October 2017.

On Wednesday, October 4, 2017, UsAgainstAlzheimer's held a National Summit in Washington D.C. Veronica Miller, PhD, the Executive Director of the Forum was one of the panelists.

 The Opening Session Panelists from left to right: Nancy Brinker (founder of Susan G Komen), The other panelists are Rita Carreon (hidden) – Institute for Hispanic Health UnidosUS, Wade Henderson (Leadership Conference on Civil and Human Rights), Veronica Miller (Forum for Collaborative Research), Isabell Sawhill (Brookings Institution/ National Campaign to Prevent Teen and unplanned pregnancy) & Mike McMurry (Former White House Secretary)

On behalf of UsAgainstAlzheimer’s and all those who attended our National Summit events last week, I write to thank you for the perspectives and insights you shared with all of us as a panelist for our opening session, Growing the Alzheimer's Movement: Learning from Others.

A message from the Social Entrepreneurship for Sexual Health (SESH)

Deadline to submit: 10 November 2017

The purpose of this call is to gather information related to health challenge contests – defined as open calls to solicit community input in order to improve public health. Descriptions of case studies, experiences organizing contests, and evaluation examples are being solicited. These cases will be reviewed by a panel based on clarity of model, effectiveness, promotion of equity, and potential for learning. Exceptional cases will be included in a global toolkit on challenge contests for health.